The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Final results of a chemoprevention trial with enzastaurin in former smokers.
J. E. Gray
Consultant or Advisory Role - Lilly
Honoraria - Lilly
S. Altiok
No relevant relationships to disclose
M. Alexandrow
No relevant relationships to disclose
F. Walsh
No relevant relationships to disclose
J. Chen
Employment or Leadership Position - Lilly
D. Tai
Employment or Leadership Position - Lilly
G. Bepler
Consultant or Advisory Role - Lilly (U)
Honoraria - Lilly
Research Funding - Lilly